TV 목록 보기
증권
지난 주요뉴스 한국경제TV에서 선정한 지난 주요뉴스 뉴스썸 한국경제TV 웹사이트에서 접속자들이 많이 본 뉴스 한국경제TV 기사만 onoff
[PRNewswire] Johnson & Johnson Announces European Commission Approval of 2020-10-09 09:38:25
a single-dose regimen in its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) [https://www.jnj.com/johnson-johnson-initiates-pivotal-global-phase-3-clinical-trial-of-janssens-covid-19-vaccine-candidate ] that started in September. A second Phase 3 study with a two-dose regimen is planned...
[PRNewswire] Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial 2020-09-24 00:27:23
Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate -- First participants dosed in Phase 3 trial (ENSEMBLE) evaluating safety and efficacy of Janssen's COVID-19 vaccine candidate, JNJ-78436735, also known as Ad26.COV2.S (NEW BRUNSWICK, New Jersey,...
[PRNewswire] AGC Biologics Expands Partnership with Novavax 2020-08-11 10:05:38
NVX-CoV2373 was generally well-tolerated and elicited robust antibody responses numerically superior to that seen in human convalescent sera in its Phase 1 data of the Phase 1/2 clinical trial. NanoFlu™, its quadrivalent influenza nanoparticle vaccine, met all primary objectives in its pivotal Pha...
[PRNewswire] Single Dose of Johnson & Johnson COVID-19 Vaccine Candidate 2020-07-30 19:41:03
a Phase 1 study in Japan. For more information about these studies, please visit www.clinicaltrials.gov. As the Company plans its COVID-19 Phase 3 clinical development program, discussions are underway with partners with the objective to start a pivotal Phase 3 clinical trial of the single vaccine...
[PRNewswire] Adecco Group의 조사, 코로나19 이후 대대적인 직장 변화 예상돼 2020-06-30 20:47:34
in pivotal shifts in attitudes and expectations among workers and leaders, as both call for permanent changes in how and where we work, workplace relationships and future skills, according to new research from the Adecco Group. The Adecco Group, the world's leading HR solutions company, today...
[PRNewswire] 노바백스, 신종 COVID-19 백신용 매트릭스-M™ 보조제 제조사로 2020-06-04 09:34:52
Novavax recently initiated development of NVX-CoV2373, its vaccine candidate against SARS-CoV-2, the virus that causes COVID-19, with Phase 1 clinical trial results expected in July of 2020. NanoFlu™, its quadrivalent influenza nanoparticle vaccine, met all primary objectives in its pivotal Phase 3...
[PRNewswire] ERBITUX(R) Approved for First-line Use in China in Patients With 2020-03-02 16:04:58
fluorouracil for the first-line treatment of R/M SCCHN -- Pivotal Phase III study shows significant improvements with ERBITUX(R) in combination with platinum-based therapy with fluorouracil in response rate, disease progression and survival compared to platinum-based chemotherapy alone -- This marks...
[PRNewswire] Tessa Therapeutics Announces U.S. FDA Regenerative Medicine 2020-02-27 21:08:13
(FDA) for the treatment of patients with relapsed or refractory CD30-positive classical Hodgkin lymphoma (cHL). Tessa expects to initiate its pivotal Phase II multi-site trial in the fourth quarter of 2020. "The RMAT designation speaks to the strength of the data in two independent Phase I/II...
[PRNewswire] Tessa Therapeutics to Open 90,000 Square Foot Commercial-Scale 2019-12-19 21:10:06
T cell (VST platform) has shown a strong safety profile and early efficacy in the treatment of solid tumors. Tessa is currently conducting two pivotal studies of autologous cell therapies in nasopharyngeal cancer and classical Hodgkin lymphoma. Tessa also has an earlier-stage clinical pipeline of...
[PRNewswire] IMI, 현대중공업 및 Bahri와 VLCC 주문 계약 체결 2019-09-18 20:57:21
a pivotal role in transforming the Kingdom into an important regional and global logistics and transportation hub. Bahri has been exploring new horizons for industry cooperation to take its vision forward. This project award, which further strengthens our strong strategic relationship with IMI and...
TV 목록 보기
증권
